Simplification with abacavir-based triple nucleosid therapy versus continued protease inhibitorbased highly active antiretroviral therapy in HIV-1 infected patients with undetectable plasma HIV-1 RNA

Autor: Clumeck, N., Goebel, F., Rozenbaum, W., Gerstoft, J., Stazewski, S., Montaner, J., Johnson, M., Gazzard, B., Stone, C., Athisegaran, R., Moore, S., behalf of the CNA30017, on

Publikováno v: Clumeck, N, Goebel, F, Rozenbaum, W, Gerstoft, J, Stazewski, S, Montaner, J, Johnson, M, Gazzard, B, Stone, C, Athisegaran, R, Moore, S & behalf of the CNA30017, O 2001, ' Simplification with abacavir-based triple nucleosid therapy versus continued protease inhibitorbased highly active antiretroviral therapy in HIV-1 infected patients with undetectable plasma HIV-1 RNA ', AIDS, vol. 15, pp. 1517-1526 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::59246f7754c34ee242ff836f1de22c2e
https://portal.findresearcher.sdu.dk/da/publications/ae369680-2baa-11dc-9480-000ea68e967b

Avanti 3: A Randomized, Double-Blind Trial to Compare the Efficacy and Safety of Lamivudine plus Zidovudine versus Lamivudine plus Zidovudine plus Nelfinavir in HIV-1-Infected Antiretroviral-Naive Patients

Autor: Gartland, Martin, Clumeck, N, Cooper, DA, Gatell, J, Gazzard, B, Gerstoft, J, Goebel, F, Lange, J, Montaner, J, Reiss, P, Rozenbaum, W, Vella, S, Cooper, DA, Haberl, M, Clumeck, N, Luyts, D, Montaner, J., Rachlis, A, Marina, R, Gerstoft, J, Mathiesen, L, Soelberg, U, Molina, J-M, Pialloux, G, Rozenbaum, W, Cosby, C, Goebel, FD, Staszewski, S, Hug, M, Milazzo, F, Moroni, M, Panebianco, R, Clotet, B, Artigas, JM Gatell, GonzalezLahoz, J, Leal, M, Gandarias, B, Gazzard, B, Johnson, M, Watkins, K, Page, V, Sandstrom, E, Darbyshire, J, Petersen, A, Athisegaran, R, Coughlan, M, Fiddian, P, Gartland, M, Harrigan, R, Henry, T, Larder, B, Maguire, M, Millard, J, Moore, S, Patel, K, Shortino, D, Tisdale, M, Vafidis, I, Yeo, J

Publikováno v: Antiviral Therapy; February 2001, Vol. 6 Issue: 2 p127-134, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.